A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in …
A Vincent, MO Whipple, SJ McAllister, KM Aleman… - BMJ open, 2015 - bmjopen.bmj.com
BMJ open, 2015•bmjopen.bmj.com
Objectives The objective of this study was to evaluate the problem of multiple chronic
conditions and polypharmacy in patients with fibromyalgia. Design Retrospective medical
record review. Setting Olmsted County, Minnesota. Participants 1111 adults with
fibromyalgia. Primary and secondary outcome measures Number and type of chronic
medical and psychiatric conditions, medication use. Results Medical record review
demonstrated that greater than 50% of the sample had seven or more chronic conditions …
conditions and polypharmacy in patients with fibromyalgia. Design Retrospective medical
record review. Setting Olmsted County, Minnesota. Participants 1111 adults with
fibromyalgia. Primary and secondary outcome measures Number and type of chronic
medical and psychiatric conditions, medication use. Results Medical record review
demonstrated that greater than 50% of the sample had seven or more chronic conditions …
Objectives
The objective of this study was to evaluate the problem of multiple chronic conditions and polypharmacy in patients with fibromyalgia.
Design
Retrospective medical record review.
Setting
Olmsted County, Minnesota.
Participants
1111 adults with fibromyalgia.
Primary and secondary outcome measures
Number and type of chronic medical and psychiatric conditions, medication use.
Results
Medical record review demonstrated that greater than 50% of the sample had seven or more chronic conditions. Chronic joint pain/degenerative arthritis was the most frequent comorbidity (88.7%), followed by depression (75.1%), migraines/chronic headaches (62.4%) and anxiety (56.5%). Approximately, 40% of patients were taking three or more medications for symptoms of fibromyalgia. Sleep aids were the most commonly prescribed medications in our sample (33.3%) followed by selective serotonin reuptake inhibitors (28.7%), opioids (22.4%) and serotonin norepinephrine reuptake inhibitors (21.0%).
Conclusions
The results of our study highlight the problem of multiple chronic conditions and high prevalence of polypharmacy in fibromyalgia. Clinicians who care for patients with fibromyalgia should take into consideration the presence of multiple chronic conditions when recommending medications.
bmjopen.bmj.com
以上显示的是最相近的搜索结果。 查看全部搜索结果